| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/21/2006 | CN1791397A Pharmaceutical combination comprising modafinil and another drug |
| 06/21/2006 | CN1791396A Combination of histone deacetylase inhibitors with chemotherapeutic agents |
| 06/21/2006 | CN1791381A Odorless formulation for treating mucosal discontinuities |
| 06/21/2006 | CN1789282A Multifunctional polypeptide |
| 06/21/2006 | CN1788792A Pharmaceutical combination for preventing and treating fallopian tube adhesion |
| 06/21/2006 | CN1788735A Use of bioactive composition derived from cattle urine distillate ('Go-mutra') as anti-infective,anti-tumour and biological intensifier of nutriment |
| 06/21/2006 | CN1788726A Pharmaceutical composition for reducing blood sugar |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1259974C Drug giving-up medicine made-up by non-thebaica medicines |
| 06/21/2006 | CN1259973C Preventives or remedies for psoriasis containing IL-6 antagonist as the active ingredient |
| 06/21/2006 | CN1259912C Citalopram for the treatment of elevated blood pressure |
| 06/21/2006 | CN1259910C Liquid drug preparations |
| 06/21/2006 | CN1259908C Hydrolysis-optimized liplid emulsions and use thereof |
| 06/21/2006 | CN1259844C Mixtures of fructose and lactose as low-calorie bulk sweetener with reduced blood sugar index |
| 06/20/2006 | US7064193 Therapeutic molecules |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064143 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., ethyl 4-hydroxy-1-methyl-1H-indole-2-carboxylate and N-methyl-N-phenethyl 4-hydroxy-1-methyl-1H-indole-2-carboxamide; used for treatment of Alzheimer's disease, anxiety or schizophrenia |
| 06/20/2006 | US7064141 Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy |
| 06/20/2006 | US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity |
| 06/20/2006 | US7064132 Administering an aerosolized mixture of lipid crystals comprised of a mixture of one or more lipids surfactants and spreading agents in powder form and propellants directly to the ear canal |
| 06/20/2006 | US7064112 selectively inhibiting abnormal cell proliferation by administering an A3-selective adenosine A3 receptor agonist in an amount of less than 100 mu g/Kg body weight. |
| 06/20/2006 | US7063973 HDAC9 polypeptides and polynucleotides and uses thereof |
| 06/20/2006 | US7063971 Phosphodiesterase enzymes |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | US7063954 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 06/20/2006 | US7063953 Human voltage gated sodium channel β1A subunit and methods of use |
| 06/20/2006 | US7063855 For aquacultural prey organisms such as Artemia and rotifiers; phospholipids and di- and triglycerides having a docosahexaenoic acid content of at least 30% |
| 06/20/2006 | US7063836 Treating intestinal infections in a ruminant by administering a Lactobacillus acidophilus strain, able producing lactic acid; gastrointestinal disorders, veterinary medicine; increasing the fat content of milk produced by a dairy cow |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2379585C Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2350943C Process for the manufacture of liquid filled capsules |
| 06/17/2006 | CA2490484A1 Treatment of obstructive sleep apnea |
| 06/15/2006 | WO2006062808A2 Stabilized products, process and devices for preparing same |
| 06/15/2006 | WO2006062681A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 06/15/2006 | WO2006062069A1 REMEDY FOR PRURITUS COMPRISING p38MAP KINASE AS THE ACTIVE INGREDIENT |
| 06/15/2006 | WO2006060898A1 Method for treating inflammatory disorders |
| 06/15/2006 | WO2006044573A3 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/15/2006 | WO2006010838A3 Products containing at least one anticancer active principle with low diffusion and an immunostimulatory active principle |
| 06/15/2006 | WO2005123076A3 Pharmaceutical compositions |
| 06/15/2006 | WO2005110494A3 Methods and compositions for the inhibition of thrombus formation |
| 06/15/2006 | WO2005092380A3 Uses of anti-ctla-4 antibodies |
| 06/15/2006 | WO2004098519A3 Ginkgo biloba extract as a treatment for therapeutic induced neurotoxicity |
| 06/15/2006 | WO2001082928A9 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060129209 Method and apparatus for the stimulation of hair growth |
| 06/15/2006 | US20060128810 Remedies for allergic diseases |
| 06/15/2006 | US20060128809 Rapidly absorbed liquid compositions |
| 06/15/2006 | US20060128802 acamprosate; Parkinson's disease or Huntington's disease |
| 06/15/2006 | US20060128792 Deguelin as a chemopreventive agent for lung cancer |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128762 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 06/15/2006 | US20060128760 Use of mglur5 antagonists for the treatment of gerd |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128751 CETP inhibitors in combination with antihypertensive agents and uses thereof |
| 06/15/2006 | US20060128746 Methods, kits and compositions for using pyrrole derivatives |
| 06/15/2006 | US20060128743 Method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs |
| 06/15/2006 | US20060128742 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 06/15/2006 | US20060128721 Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives |
| 06/15/2006 | US20060128705 Method of treating chronic fatigue syndrome |
| 06/15/2006 | US20060128687 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/15/2006 | US20060128666 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128644 Use of mob-5 in pain |
| 06/15/2006 | US20060128643 Compositions containing a combination of a creatine compound and a second agent |
| 06/15/2006 | US20060128640 Combination of a taxane and a cyclin-dependent kinase |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127900 Method for detecting increased susceptibility to tumors |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127503 Ulcerative colitis and Crohn's disease; 5-aminosalicylic acid or 4-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) |
| 06/15/2006 | US20060127499 Vitamin-mineral compositions |
| 06/15/2006 | US20060127497 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 06/15/2006 | US20060127478 Oral dosage formulation |
| 06/15/2006 | US20060127477 Novel preparation and administration form comprising an acid-labile active compound |
| 06/15/2006 | US20060127452 Method and composition for reducing cravings for a craved substance |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127440 Drug delivery systems for the prevention and treatment of vascular diseases |
| 06/15/2006 | US20060127431 Agmatine combined with BHT, BHA, hexamidine, cetyl pyridinium chloride, green tea catechins, phytosterols, ursolic acid and/or plant extracts in carrier; reducing shaving frequency |
| 06/15/2006 | US20060127417 administering the toxin directly to a blood vessel, especially following a cardiovascular procedure. |
| 06/15/2006 | US20060127321 Pharmaceutical foam |
| 06/15/2006 | US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems |
| 06/15/2006 | US20060127307 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 06/15/2006 | CA2638753A1 Methods, assays and compositions for treating retinol-related diseases |
| 06/15/2006 | CA2589746A1 Methods for diagnosis and treatment of crohn's disease |
| 06/15/2006 | CA2587523A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 06/14/2006 | EP1669092A1 Preparation for the prophylaxis of restenose |
| 06/14/2006 | EP1669090A1 Bitterness-masking particulate jelly beverage |
| 06/14/2006 | EP1669089A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 06/14/2006 | EP1669088A1 METHOD OF TREATING DIABETES BY INHIBTING DEGRADATION OF AT LEAST ONE OF CREBL1, ATF6 and HNF-4 ALPHA BY HtrA2 |
| 06/14/2006 | EP1669087A1 Preparation containing basic drug |
| 06/14/2006 | EP1669085A1 Medical agent for prevention and/or treatment of alzheimer disease |
| 06/14/2006 | EP1669080A1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein |
| 06/14/2006 | EP1669077A1 Antibacterial compositions of n-acetyl-d-aminoglycosamine and antibiotics |
| 06/14/2006 | EP1669067A2 Flavonoids for cystic fibrosis therapy |
| 06/14/2006 | EP1668128A1 Treatment of menorrhagia, dysmenorrhoea or endometriosis |